Non-small-cell lung cancer: how to manage EGFR-mutated disease

• Main Authors: Federica Pecci (Author), Luca Cantini (Author), Giulio Metro (Author), Biagio Ricciuti (Author), Giuseppe Lamberti (Author), Ammad Ahmad Farooqi (Author), Rossana Berardi (Author)
• Format: Book
• Published: BioExcel Publishing Ltd, 2022-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The treatment of non-small-cell lung cancer (NSCLC) harbouring EGFR mutations has witnessed some major breakthroughs in the last years. On the one hand, the recent advent of the third-generation tyrosine kinase inhibitor (TKI) osimertinib has reshaped the therapeutic algorithm both in the first-line...